Common equity shares of Stereotaxis, Inc. (NYSE American: STXS) exhibit a high degree of price volatility, which is characteristic of micro-cap medical device and clinical-stage biotechnology equities. Because the company’s market capitalization is relatively small, daily trading volumes can be thin, meaning minor shifts in institutional sentiment, quarterly earnings disclosures, regulatory updates regarding catheter approvals, or broader small-cap market trends can trigger sharp percentage price swings during active trading sessions.